Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
Aleksandra Wojtas(Mayo Clinic in Arizona), John Denis Fryer(Mayo Clinic in Arizona)
Cited by 53
Related Papers
Long-read sequencing across the C9orf72 ‘GGGGCC’ repeat expansion: implications for clinical use and genetic discovery efforts in human disease
|Molecular Neurodegeneration|2018|131
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations
|The Journal of Experimental Medicine|2024|52